Company Description

MindWalk Holdings Corp. operates as a bio-native AI company.

The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology.

The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025.

The company was incorporated in 1983 and is headquartered in Austin, Texas.

MindWalk Holdings Corp.

Country	United States
Founded	1983
IPO Date	Jan 3, 2017
Industry	Biotechnology
Sector	Healthcare
Employees	77
CEO	Jennifer Bath

Contact Details

Address: Industrious 823 Congress Ave, Suite 300 Austin, Texas 78701 United States
Phone	800 620 4187
Website	mindwalkai.com

Stock Details

Ticker Symbol	HYFT
Exchange	NASDAQ
Fiscal Year	May - April
Reporting Currency	CAD
CIK Code	1715925
CUSIP Number	602687105
ISIN Number	CA6026871054
SIC Code	2834

Key Executives

Name	Position
Dr. Jennifer Lynne Bath Ph.D.	Chief Executive Officer, President and Non-Independent Director
Richard Scott Areglado	Chief Financial Officer
Dr. Thomas Lynch Ph.D.	Chief Business Officer
Kari Graber	Vice President of Commercial Services
Dr. Shuji Sato	Vice President of Innovative Solutions
Dirk Van Hyfte M.D., Ph.D.	Chief Technology Officer
Frederic Chabot	Head of Corporate Development
Ingrid Brands M.D., Ph.D.	Chief Innovation and Strategy Officer
Lori Anderson	Vice President of Brand Marketing and Creative

Latest SEC Filings

Date	Type	Title
Jul 30, 2026	EFFECT	Notice of Effectiveness
Jul 28, 2026	F-3/A	Filing
Jul 23, 2026	6-K	Report of foreign issuer
Jul 23, 2026	20-F	Annual and transition report of foreign private issuers
Jul 22, 2026	6-K	Report of foreign issuer
Jul 13, 2026	F-3	Filing
Jul 13, 2026	6-K	Report of foreign issuer
Jul 6, 2026	6-K	Report of foreign issuer
Jul 1, 2026	6-K	Report of foreign issuer
Jun 12, 2026	6-K	Report of foreign issuer

View All SEC Filings